HaemoscoreWith this interactive application, you can now access useful Scores and Algorithm recognised by the scientific community at any time.www.haemoscore.comUseful Scores and Algorithm
stago.com was registered 2 decades 6 years ago. It has a alexa rank of #1,321,082 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, stago.com is SAFE to browse.
Daily Unique Visitors: | 664 |
Daily Pageviews: | 1,328 |
Income Per Day: | $ 4.00 |
Estimated Worth: | $ 960.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: |
![]() |
WOT Privacy: |
![]() |
WOT Child Safety: |
![]() |
Alexa Rank: | 1,321,082 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: |
49 ON 100 ![]() |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
By continuing to browse this site, you agree to the placement of cookies on your computer that allow us to measure the website's audience and improve the ...
Catalogue. This website contains information on products which is targeted to a ...
Stago Canada Ltd/Ltée (SCL) is the exclusive provider of the Diagnostica ...
Diagnostica Stago Hong Kong Ltd · Stago Österreich GmbH · Diagnostica Stago ...
Stago inthe USA. Diagnostica Stago, Inc., (DSI) is an industry leader in the science of hemostasis and thrombosis. Stago provides the total ...
Welcome to Stago Webinars! Recognised by the international scientific community for its essential contribution to advances in Haemostasis, Stago is committed ...
About us. Created in 1945 as a pharmaceutical company, Diagnostica Stago is now a world leader in the In-Vitro Diagnostics industry. Global, privately-owned ...
View Stago Group Companies (www.stago.com) location in Ile-de-France, France , revenue, industry and description. Find related and similar companies as ...
Diagnostica Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer ...
We take a lot of things for granted, especially when it comes to the functions of our body. Our heart beats. Our lungs breathe. Our blood flows. But however young ...
Stago is a pharmaceutical company with a strong interest in clinical pathology and in Haemostasis.
(iOS and Android). This scientific initiative was produced with the help of www. stago.com. A practical Manual printed is also available. Reference number: 28111.
Home for Stago's Open Source software. Stago has 14 repositories available. Follow their code on GitHub.
Diagnostica Stago uses 9 email formats: 1. first '.' [email protected] (77.8%). Enter a name to find & verify an email >>>
DIAGNOSTICA STAGO START MAX. Perehdytysvideo sekä kirjallinen käyttöohje . Reetta Heikkilä, Henna Kinnunen &. Erja Metsämarttila. Opinnäytetyö.
Stago, created in 1945, is an IVD Company which develops and markets reagents and automated systems for the investigation of blood coagulation disorders.
30 May 2017 ... Created in 1945, Stago is fully dedicated to Haemostasis since 1962. Privately- owned and independent, Stago is headquartered in Asnières, ...
Ask Stago: EXPERT ANSWERS TO YOUR EXPERT QUESTIONS Ask Stago is the weekly podcast for Hemostasis laboratory professionals. In less than 10 ...
Created in 1945 as a pharmaceutical company, Diagnostica Stago is now a world leader in the In-Vitro Diagnostics industry. Global, privately-owned and indepe ...
Stago markets its product brands in over 110 countries with: • A constantly expanding network of subsidiaries. • A network of regularly evaluated distributors. • R&D ...
H1 Headings: | 4 | H2 Headings: | 4 |
H3 Headings: | 2 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 14 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Stago Group | 8 | 1.401 % | No |
is in | 4 | 0.701 % | No |
Diagnostics is | 4 | 0.701 % | No |
of the | 4 | 0.701 % | No |
in our | 4 | 0.701 % | No |
our blood | 4 | 0.701 % | No |
blood Generate | 4 | 0.701 % | No |
Contact us | 4 | 0.701 % | No |
Satellite Max | 3 | 0.525 % | No |
STA Satellite | 3 | 0.525 % | No |
Max Generation | 3 | 0.525 % | No |
History of | 3 | 0.525 % | No |
to the | 3 | 0.525 % | No |
Stago in | 2 | 0.35 % | No |
Clinical Applications | 2 | 0.35 % | No |
Stago Podcasts | 2 | 0.35 % | No |
Presentation Stago | 2 | 0.35 % | No |
Message of | 2 | 0.35 % | No |
Group websites | 2 | 0.35 % | No |
of Thrombosis | 2 | 0.35 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
in our blood Generate | 4 | 0.701 % | No |
Diagnostics is in our | 4 | 0.701 % | No |
is in our blood | 4 | 0.701 % | No |
length of stay and | 1 | 0.175 % | No |
of stay and cost | 1 | 0.175 % | No |
stay and cost effectiveness | 1 | 0.175 % | No |
shorter length of stay | 1 | 0.175 % | No |
experience shorter length of | 1 | 0.175 % | No |
outcomes and experience shorter | 1 | 0.175 % | No |
and experience shorter length | 1 | 0.175 % | No |
and cost effectiveness drive | 1 | 0.175 % | No |
cost effectiveness drive the | 1 | 0.175 % | No |
of value in today’s | 1 | 0.175 % | No |
value in today’s rapidlyevolving | 1 | 0.175 % | No |
in today’s rapidlyevolving and | 1 | 0.175 % | No |
recognition of value in | 1 | 0.175 % | No |
the recognition of value | 1 | 0.175 % | No |
effectiveness drive the recognition | 1 | 0.175 % | No |
drive the recognition of | 1 | 0.175 % | No |
patient outcomes and experience | 1 | 0.175 % | No |
Domain Registrar: |
CSC Corporate Domains, Inc.
![]() |
---|---|
Registration Date: | 1998-04-21 2 decades 6 years 9 months ago |
Last Modified: | 2020-04-16 4 years 10 months 9 hours ago |
Host | IP Address | Country | |
---|---|---|---|
udns1.cscdns.net | ![]() |
204.74.66.1 | ![]() |
udns2.cscdns.uk | ![]() |
204.74.111.1 | ![]() |
Host | Type | TTL | Extra |
---|---|---|---|
stago.com | A | 86370 |
IP: 89.30.106.52 |
stago.com | NS | 86400 |
Target: udns2.cscdns.uk |
stago.com | NS | 86400 |
Target: udns1.cscdns.net |
stago.com | SOA | 86400 |
MNAME: udns1.cscdns.net RNAME: premiumdns.support.neustar Serial: 2019110907 Refresh: 21600 Retry: 7200 Expire: 2419200 |
stago.com | MX | 300 |
Priority: 10 Target: cust61455-1.in.mailcontrol.com |
stago.com | MX | 300 |
Priority: 5 Target: cust61455-2.in.mailcontrol.com |
stago.com | TXT | 86400 |
TXT: MS=ms78473260 |
stago.com | TXT | 86400 |
TXT: cisco-ci-domain-verification=6cc70c1bf2e 4c63bca9ecf98e4c6cf404f57de16e4f139a14a4 a8cc67bec4346 |
stago.com | TXT | 86400 |
TXT: apple-domain-verification=NWBURiYNqI6C8L A5 |
stago.com | TXT | 86400 |
TXT: apple-domain-verification=eFJitHtC9IuGGc Pl |
stago.com | TXT | 86400 |
TXT: docusign=5b97564b-447a-4542-bd03-6fb0215 3dffd |
stago.com | TXT | 86400 |
TXT: docusign=88489416-1aa5-406d-859c-0b35d2e 9c0d7 |
stago.com | TXT | 86400 |
TXT: v=spf1 include:mailcontrol.com include:spf.protection.outlook.com ~all |